LinusBio Raises $16M for Novel Diagnostics Platform that Can Help Diagnose Autism Early
LinusBio raised over $16 million to deliver a novel platform that bridges genomics, the environment, and biological response.
Read MorePosted by Andy Lundin | Jan 16, 2023 | Company News, Diagnostic Technologies |
LinusBio raised over $16 million to deliver a novel platform that bridges genomics, the environment, and biological response.
Read MorePosted by Andy Lundin | Jan 16, 2023 | Company News, Diagnostic Technologies |
NuraLogix unveiled a platform that performs continuous health and vital sign measurements while on a video telemedicine call.
Read MorePosted by Andy Lundin | Jan 13, 2023 | Disease States |
Twist Bioscience and Centogene N.V. launched three NGS target enrichment panels to support rare disease and hereditary cancer diagnostics.
Read MorePosted by Chris Wolski | Jan 9, 2023 | Molecular Diagnostic Analyzers |
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read MorePosted by Andy Lundin | Jan 6, 2023 | Womens Health |
A new study by investigators embarked on a study to create a targeted test for predicting placenta accreta spectrum (PAS) during pregnancy.
Read More